Business Context and Reporting Period
This Form 8-K Current Report was filed by ChromaDex Corporation on November 5, 2015, regarding events occurring on November 4, 2015. The filing details the entry into a Material Definitive Agreement for a registered direct offering of securities to certain existing stockholders.
Key Financial Metrics and Transaction Details
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, or debt levels. Instead, it outlines the terms of a capital raise:
- Units Sold: 200,000 Units.
- Purchase Price: $10.00 per Unit.
- Unit Composition: Each Unit consists of 8 shares of Common Stock and 1 Warrant to purchase 4 shares of Common Stock.
- Warrant Terms: Exercise price of $1.50 per share; exercisable immediately; expires three years from issuance.
- Ownership Limitation: Holders are restricted from exercising warrants if it would result in beneficial ownership exceeding 4.99% of outstanding shares.
- Expected Closing: On or about November 9, 2015.
Material Changes
The primary material change is the execution of Securities Purchase Agreements for the sale of equity and warrants. The filing does not provide comparative financial data against prior periods as it is a transactional report rather than a periodic financial statement.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on future operations, or specific risk factors beyond standard contractual provisions. The transaction is subject to customary closing conditions. The Company explicitly states that the Purchase Agreement representations are not intended for public investors to obtain factual information about the Company's current state of affairs.
Investor Verification Checklist
- Verify the final closing date and total gross proceeds upon completion of the offering.
- Review the full text of the Securities Purchase Agreement (Exhibit 10.01) and Warrant (Exhibit 10.02) for specific covenants and adjustment mechanisms.
- Confirm the impact of the 200,000 Units (1.6 million shares + warrants) on total share count and potential dilution.
- Check subsequent filings for the actual use of proceeds and any changes to the offering terms.